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Abstract  Cardiovascular disease (CVD) is a leading cause of further morbidity and mortality in type 2 
diabetes patients. This study aimed to find the serum lipid profile, serum uric acid levels, other CVD risk 
factors, and how these factors are affected by diabetes duration in adults with type 2 diabetes. The cross-
sectional study, involving 100 subjects, was carried out at the Diabetes Centre, Komfo Anokye Teaching 
Hospital (KATH), Kumasi, Ghana. Adult type 2 diabetes patients, 20 years or older, were recruited for the 
study. The National Cholesterol Education Program (NCEP) Adult Panel III and American Diabetes 
Association (ADA) guidelines were used to find the metabolic status of the patients. Of the 100 patients, 74% 
and 62% had high systolic blood pressure and abdominal obesity, respectively. Also, high LDL-cholesterol and 
hypercholesterolaemia were found in 47% and 46% of the patients, respectively. Forty-six percent (46%) of the 
patients were hyperuricaemic. Cardiovascular disease risk increased with age from 20 to 79 years. The female 
diabetics had more adverse CVD risk profile than the male diabetics (high LDL, 55% vs. 23.1%; high total 
cholesterol, 54.1% vs. 23.1%; high triglycerides, 32.4% vs. 30.8%; low HDL, 25.7% vs. 3.8%). Fifty percent 
(50%) of females compared to 34.6% of males were hyperuricaemic. However, hypertension was more 
prevalent among males (systolic blood pressure, 76.9%; diastolic blood pressure, 38.5%) than among females 
(systolic blood pressure, 73%; diastolic blood pressure, 37.8%). In conclusion, the prevalence of 
hyperuricaemia and other cardiometabolic risks was high among type 2 diabetes patients. 
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1. Introduction
Cardiovascular disease is a leading cause of death
in type 2 diabetes patients.[1] The metabolic 
determinants of CVD include serum lipid profile, 
serum uric acid, blood glucose, blood pressure (BP), 
body mass index (BMI), and waist circumference 
(WC). Dyslipidaemia (i.e. high total cholesterol, high 
LDL-cholesterol, high triglycerides and low HDL-
cholesterol) is a significant CVD risk factor.[2] It is 
common in type 2 diabetes patients causing both 
microvascular and macrovascular complications.[3,4] 
Insulin deficiency and resistance affect pathways and 
enzymes of lipid metabolism.[5] The most common 
abnormality is increased serum triglyceride levels, 
followed by decreased serum HDL-cholesterol levels 
and increased serum LDL-cholesterol levels.[6,7] 
Many of the patients are overweight, with some even 
overtly obese.[7] Total cholesterol:HDL-cholesterol 
ratio (TC:HDL-C) as well as LDL-cholesterol:HDL-
cholesterol ratio is also an index of CVD, the former 
being a better indicator.[8] Hyperuricaemia has been 
related to CVD. Hyperuricaemia increased the 
prevalence of metabolic syndrome, and was 
associated with abdominal obesity, 
hypertriglyceridaemia, low HDL-cholesterol, and 
high BP among type 2 diabetics.[9-11]  
    High BP is a cardiovascular risk factor and this 
is more severe in patients with type 2 diabetes.[12] A 
combined increase in systolic blood pressure (SBP) 
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and decrease in diastolic blood pressure (DBP), 
however, is a higher CVD risk factor.[13] Body mass 
index, a measure of obesity, is the ratio of weight in 
kilogram to the square of height in metre. It is a 
common parameter measured in investigative studies 
involving patients with type 2 diabetes, hypertension, 
dyslipidaemia, and obesity. The higher the BMI, the 
greater the risk for these disorders.[14] Other 
anthropometric indices that have been used to study 
risks for metabolic diseases include WC[15] and waist-
to-hip ratio.[16] Body mass index, when used in 
combination with WC, has proven to be a better 
indicator of cardiometabolic disorder and CVD.[17,18] 
In urban Ghana, type 2 diabetes which is associated 
with age and obesity affects at least, 6% of adults.[19] 
Overweight, which has been related to advancing age, 
female gender, urban environment, high income, and 
tertiary education affects about 23% of adults.[20] This 
study aimed to find the blood lipid profile, uric acid 
level and anthropometric indices of type 2 diabetes 
patients, and how diabetes duration affects these 
parameters.  
2. Materials and Methods
Study design 
This study was cross-sectional, involving 100 type 
2 diabetes patients who visited the Diabetes Centre of 
the Komfo Anokye Teaching Hospital (KATH), 
Kumasi, Ghana, as out-patients. These patients were 
with or without complications. 
Inclusion and exclusion criteria 
Only type 2 diabetes patients of 20 years or older 
at the Out-patient Department (OPD) were recruited 
in the study. They should have been registered at the 
Diabetic Centre, and their medical records should be 
available. Type 1 diabetes patients and gestational 
diabetes women were excluded from the study. 
Anthropometric and BP measurements 
The weights of the subjects were taken using an 
electronic scale, Seca Ltd., Germany and their 
heights measured with the stadiometer, Seca Ltd., 
Germany. The BMI for each subject was then 
calculated as weight in kilogram divided by height in 
metre squared, and this determined central obesity. 
Waist circumference, which determined abdominal 
obesity, was measured (in centimetre), with a tape 
measure. The measurement was taken, midway 
between the lower border of the rib cage and the iliac 
crest, in the mid axillary line, with patients standing 
and breathing normally. 
Patients were allowed to rest for 20 minutes prior 
to measuring their BP. Blood pressure was measured 
by standard methods using a mercury 
sphygmomanometer and a stethoscope with the 
patient in a sitting position. Three measurements 
were made on all subjects at 5-minute intervals; the 
average of the measurements was used in the analysis. 
These measurements were made by trained personnel 
to ensure accuracy. 
Biochemical measurements 
About 5 ml of venous blood samples were 
collected (by a phlebotomist) in the morning from 
subjects who had fasted for at least 8 hours. Two 
millilitre (2 ml) of each sample was kept in fluoride 
tube and the remaining in serum tube. Laboratory 
tests were conducted on blood samples of subjects to 
find serum lipid profile (total cholesterol, HDL-
cholesterol, LDL-cholesterol and triglycerides), 
fasting blood glucose (FBG), and uric acid.   
    Fasting blood glucose was estimated by 
Trinder's method, an end point/ fixed time assay, with 
a kit from Fortress Diagnostics, UK. The total 
cholesterol was determined by the cholesterol 
oxidase-peroxidase (CHO-POD) method, with kits 
from Medsource Ozone Biomedicals, Pvt. Ltd., India. 
Triglycerides were determined by the glycerol-3-
phosphate oxidase-peroxidase (GPO-POD) method, 
with kits from Fortress Diagnostics, UK and HDL-
cholesterol was determined by the precipitation end-
point method with reagents from Fortress Diagnostics, 
UK. LDL-cholesterol concentration was calculated 
by Friedewald’s formula.[21] Serum uric acid levels 
were determined by uricase-peroxidase (Uricase-
POD), end point assay method,[22] with reagents from 
Medsource Ozone Biomedicals, Pvt. Ltd, Haryana, 
India. The Kenza BioChemis Try, BIOLABO 
Diagnostics, France, a semi-automated 
spectrophotometer, was used to measure all the 
parameters. The TC:HDL-C ratio, referred to as 
coronary risk, was calculated. 
Definition of diabetes 
Diabetes was defined, based on WHO diagnosis of 
diabetes, as FBG ≥ 6.1 mmol/L,[23] and/or persons 
who had been previously diagnosed by a medical 
doctor or were on diabetes medication.  Diabetes 
duration was defined as the number of years a subject 
had been with diabetes since diagnosis. 
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Definition of hyperuricaemia and other 
cardiometabolic risk factors 
High blood uric acid levels were defined as serum 
uric acid concentration > 360 µmol/L for females, 
and > 420 µmol/L for males.[24] The undesirable lipid 
profile (high total cholesterol, high LDL-cholesterol, 
high triglycerides, and low HDL-cholesterol) is as 
follows: total cholesterol ≥ 5.2 mmol/L, LDL-
cholesterol ≥ 3.0 mmol/L, triglycerides ≥ 1.71 
mmol/L, and HDL-cholesterol < 1.03 mmol/L for 
males; < 1.3 mmol/L for females. A subject was 
considered to have dyslipidaemia if at least one of the 
above criteria is attained.[25,26] Overweight and 
obesity were defined according to BMI (overweight, 
25.0–29.9 kg/m2; obesity, ≥ 30.0 kg/m2) and WC 
(overweight men, 94.0-101.9 cm; overweight women, 
80.0-87.9 cm; obese men, ≥ 102.0 cm; obese women, 
≥ 88.0 cm).[6] A subject was considered hypertensive 
if the subject had SBP ≥ 130 mmHg and DBP ≥ 85 
mmHg, or on anti-hypertensive drug.[25,26] 
Statistical analysis 
The data for this study was analysed using 
Statistical Package for Social Sciences (SPSS Inc., 
software version 20.0). Means and standard 
deviations for continuous variables were calculated 
and compared by one-way ANOVA. Comparisons of 
frequency counts and percentages for categorical 
variables between male and female diabetics were 
done using Student’s t-test. P value < 0.05 was 
considered significant for comparisons between 
groups. 
Ethical approval and informed consent 
The study protocol was forwarded to the 
Committee on Human Research, Publications and 
Ethics of the School of Medical Sciences of Kwame 
Nkrumah University of Science and Technology, and 
Komfo Anokye Teaching Hospital, Kumasi, Ghana, 
which gave approval to the research. Informed 
written consent was obtained from all subjects in the 
study. 
3. Results
Anthropometric, blood pressure, and biochemical 
indices 
The anthropometric indices, lipid profile and uric 
acid of the subjects are shown in Table 1. The mean 
BMI of the female participants was significantly 
higher (p=0.002) than that of the male participants. 
The mean total cholesterol and mean LDL-
cholesterol of females were also significantly higher 
(p=0.042 for total cholesterol; p=0.039 for LDL-
cholesterol) than those of males. Though not 
significant, females had higher mean waist 
circumference, DBP, FBG, triglycerides, HDL-
cholesterol, TC:HDL-C and uric acid, but lower 
mean SBP than males. 
Table 1: Mean anthropometric indices, BP, lipid profile and uric acid by gender 
Parameters Male 
n = 26 
Female 
n = 74 
Total 
N = 100 
p-value 




92.7 ± 12.8 
137.3 ± 17.8 
78.9 ± 10.7 
97.5 ± 14.8 
134.46 ± 18.6 







FBG (mmol/L) 9.7 ± 4.9 10.5 ± 5.0 10.3±4.9 0.479 
TC (mmol/L) 4.7 ± 1.2 5.3 ± 1.3 5.2±1.3    0.042* 




Uric acid (µmol/L) 
1.4 ± 0.4 
2.6 ± 0.9 
3.3 ± 0.7 
381.8 ± 164.2 
1.5 ± 0.4 
3.1 ± 0.1 
3.7 ± 0.9 






   0.039* 
0.102 
0.533 
Values are recorded as Mean ± Standard deviation; *indicates significant difference. Body mass index (BMI), waist circumference (WC), fasting 
blood glucose (FBG), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), triglycerides (TG), high-density 
lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C).  
The prevalence of cardiometabolic risks by gender 
Table 2 shows the prevalence of dyslipidaemia, 
hyperuricaemia, hypertension, obesity and 
hyperglycaemia by gender. The percentage of 
subjects with raised body mass index, raised waist 
circumference, elevated FBG level, elevated 
triglyceride, elevated total cholesterol, elevated LDL-
cholesterol, reduced HDL-cholesterol, and elevated 
uric acid were higher in females than in males. 
Conversely, hypertension was more prevalent among 
males than among females as the percentages of SBP 
as well as DBP of the patients were more elevated in 
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males than in the females. Interestingly, 80% of the 
participants had normal HDL-cholesterol (HDL-
cholesterol > 1.03 mmol/L for males;  and > 1.3 
mmol/L for females ).  
Table 2: Prevalence of dyslipidaemia, hypertension, obesity, hyperglycaemia and hyperuricaemia by gender 









< 18.5 Underweight 
18.5-24.9 Normal 
25.0-29.9 Overweight 
≥ 30 Obese 
< 94.0 Normal 
94.0-101.9 Overweight 
≥ 102 Obese 
< 80 Normal 
80.0-87.9 Overweight 

































FBG (mmol/L) < 6.1 Normal 









< 130 Normal 
≥ 130 High 
< 85 Normal 





















< 5.2 Normal 
≥ 5.2 High 
< 1.7 Normal 
≥ 1.7 High 
< 1.03 Normal 
≥ 1.03 High 
< 1.3 Normal 
≥ 1.3 High 
< 3.0 Normal 



































Uric acid (µmol/L) > 420 High males 







Values are recorded as Mean ± Standard deviation; p-value represents significance between male and female for low HDL-C, obese, and high 
categories of other parameters at p<0.05; *indicates significant difference. n is the number of males or females in a particular category, 
percentages are in parentheses. Body mass index (BMI), waist circumference (WC), fasting blood glucose (FBG), systolic blood pressure (SBP), 
diastolic blood pressure (DBP), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein 
cholesterol (LDL-C). Not applicable (N/A). 
Table 3: Age distribution of some CVD risk factors 
Components Age groups (years) 
20-39 40-59 60-79 ≥ 80 Total 
WC (≥102 cm for males; ≥88 cm for females) 2 24 35 1 62 
FBG (≥ 6.1 mmol/L) 1 41 39 0 81 
SBP (≥ 130 mmHg) 0 30 44 0 74 
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DBP (≥ 85 mmHg) 0 18 20 0 38 
TC (≥ 5.2 mmol/L) 1 23 22 0 46 
TG (≥1.7 mmol/L) 0 14 17 1 32 
HDL-C (< 1.03 mmol/L for males; < 1.3 
mmol/L for females) 
1 8 11 0 20 
LDL-C (≥ 3.0 mmol/L) 2 22 23 0 47 
Uric acid (> 420 µmol/L for males; >360 
µmol/L for females) 
0 24 21 1 46 
Waist circumference (WC), fasting blood glucose (FBG), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), 
triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C).
The number of subjects with various CVD risk 
factors, according to NCEP criteria, was stratified by 
age groups. These are shown in Table 3. Generally, 
the 60-79 age group had the highest number of 
subjects for all factors, except FBG (highest in the 
ages between, 40-59). Apart from FBG which was 
obviously high, BP and WC were seen to be the risk 
factors with the highest frequencies. The lowest risk 
was recorded with low HDL-cholesterol. The highest 
number of subjects with hyperuricaemia was 
recorded within the 40-59 age group, followed by the 
60-79 age group. 
The relation of diabetes duration to 
anthropometric indices, FBG, BP, serum lipid 
profile, and uric acid 
As shown in Table 4, WC was significantly 
different between the categories of diabetes duration. 
The WC increased with diabetes duration between 1 
to 19 years. Mean BMI of subjects within 11-19 
years of diabetes duration was significantly higher 
than that of those within 1-5 years of diabetes 
duration. Mean FBG for both 6-10 and ≥ 20 years of 
diabetes duration were significantly lower than for 1-
5 years of diabetes duration. Generally, the 
differences between the diabetes duration categories 
for the other parameters measured did not show any 
particular pattern. 
Table 4: Anthropometric indices, FBG, SBP, DBP, serum lipid profile and uric acid by diabetes duration 
Parameter < 1 year 1-5 years 6-10 years 11-19 years ≥ 20 years 
n   8   23   34   26   9 
BMI (kg/m2) 27.55±3.44 25.20±4.92a 27.91±6.00 28.84±6.51b 26.12±4.93 
WC (cm) 97.9±11.8a 86.5±14.6b 98.7±11.9a 101.1±15.2a 96.0±13.1 
FBG (mmol/L) 9.6±5.7 12.4±6.4b 9.4±4.5a 10.5±3.9 8.2±2.6a 
SBP (mmHg) 132.5±16.7 130.4±17.4 137.4±18.8 139.0±16.7 130.6±24.3 
DBP (mmHg) 78.8±9.9 78.3±12.3 82.2±11.8 80.4±11.8 74.4±11.3 
TC (mmol/L) 5.4±0.7 5.0±1.2 5.3±1.4 4.9±1.4 5.4±0.8 
TG (mmol/L) 1.7±0.8 1.4±0.8 1.7±0.9 1.4±0.6 1.6±0.9 
HDL-C (mmol/L) 1.5±0.3 1.5±0.3 1.5±0.4 1.4±0.4 1.5±0.2 
LDL-C (mmol/L) 3.1±0.6 2.9±0.9 3.1±1.3 2.8±1.2 3.2±1.1 
TC:HDL-C 3.6±0.8 3.3±0.5 3.8±1.1 3.5±0.8 3.7±0. 9 










Values are recorded as Mean ± Standard deviation; n is the number of subjects within a duration category. Different superscripts (a and b) between 
categories indicate that the categories were significantly different (p < 0.05) for parameter. Body mass index (BMI), waist circumference (WC), 
fasting blood glucose (FBG), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein 
cholesterol (LDL-C), systolic blood pressure (SBP), diastolic blood pressure (DBP).
4. Discussion
Overweight was more prevalent among the
females (33.8%) than among the males (30.8%) 
(Table 2). Seventy-eight percent (78%) of the 
diabetes patients had their WC beyond the normal 
range. The prevalence of obesity was also higher 
among the females (BMI, 35.1%; WC, 75.7%) than 
among the males (BMI, 11.5%; WC, 23.1%). This is 
similar to results obtained in earlier studies on 
prevalence of obesity.[4,27-29] From Table 4, WC as 
well as BMI was associated with diabetes duration; 
the longer the duration of the condition, the greater 
the WC and the BMI. This trend however, did not 
include < 1 year and > 19 years of diabetes duration. 
The patients who had been with the condition for 11-
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19 years had the highest WC and BMI. A study by 
Gautier et al.[30] which focused on the association of 
WC with the incidence of type 2 diabetes, found that 
individuals with high WC had higher risk of type 2 
diabetes. According to Bays et al.,[14] BMI also 
increases the risk of type 2 diabetes. Contrary to WC 
and BMI, mean FBG decreased with increasing 
diabetes duration as it was highest within 1-5 years of 
diabetes duration compared to 6-10 and ≥ 20 years of 
diabetes durations. Since management of type 2 
diabetes does not delay after diagnosis, longer 
duration of management might have caused the lower 
FBG in the two groups.   
Hyperlipidaemia was a common condition with 
type 2 diabetes patients in this study (Table 2). A 
study by Meigs et al.[31] supports this finding. High 
LDL-cholesterol was the commonest lipid profile 
abnormality in this study and the second, high total 
cholesterol. This contradicts an earlier study by 
Jha,[27] which found total cholesterol to be higher 
among patients than LDL-cholesterol levels. The 
prevalence of low HDL-cholesterol was higher 
among patients within 60-79 years, as compared to 
younger patients, a similar finding to that of Jha,[27] in 
which, low HDL-cholesterol was found to be more 
common in patients > 60 years than those <60 years 
of age. As shown in Table 3, CVD risk factors were 
commonest in type 2 diabetes patients within the ages 
of 60-79 years, followed by 40-59 years of age. This 
is similar to findings in studies by Hu et al.[32] and 
Ogbera,[33] in which the prevalence of CVD risk 
factors increased with age.  However, Al-Mukhtar et 
al.[34] found cardiovascular risk factors to be 
significantly higher among young type 2 diabetes 
adults (< 60 years), compared to their older 
counterparts. High SBP (≥ 130 mmHg) and DBP (≥ 
85 mmHg) were more prevalent among the males 
than among the females, with the former being more 
prevalent. The higher prevalence of SBP may explain 
why it has been suggested to be the target of 
antihypertensive treatment.[12,35] Most of the diabetics 
in the present study were on anti-hypertensive drugs. 
Hypertension frequently exists at time of diagnosis of 
type 2 diabetes and is associated with CVD risks.[36]
Patients with hypertension are more likely to have 
hyperlipidaemia. There is some evidence that 
hyperlipidaemia itself may be a risk factor for 
hypertension and that lipid-lowering interventions 
may also lower BP. Type 2 diabetes and hypertension 
together pose a higher cardiovascular risk in patients 
with metabolic syndrome.[34,37] The results of 
Danquah et al.[4] in an earlier study conducted at the 
Diabetes Centre, KATH, are slightly different from 
the findings of this study. Danquah et al. reported 
mean SBP, mean DBP, mean total cholesterol and 
mean LDL-cholesterol higher than the findings of the 
present study. Also, mean BMI, mean triglyceride 
and mean HDL-cholesterol were lower than those 
reported in this study. Danquah et al.[4] thus, 
generally reported higher CVD risk profile. The 
difference may be due to improvement in lifestyles of 
patients at the Diabetes Centre over the period 
between these two studies. As shown in Table 1, the 
mean coronary risk (TC:HDL-C) was 3.6. This is 
within the normal ratio of less than 5.0, though higher 
than the optimum of 3.5. Further, only 6% of the 
diabetics had CVD risk ratio greater than 5.0.  
Close to half (46%) of the study population had 
hyperuricaemia (Table 2), with the highest 
prevalence seen in patients within the age range of 
40-59 years (Table 3). The majority of the 
hyperuricaemic patients were females, as reported in 
a study by Wang et al.[38]  
In the present study, women had more adverse 
cardiovascular risk profile than the men. Such 
findings had been reported in earlier studies.[4,39-42] 
Results of other studies have shown obesity to be 
associated with increased CVD risks.[15,43] In a cross-
sectional study of postmenopausal women, 
Hernandez-Ono et al.[44] found visceral fat, a 
determinant of obesity, to be directly linked with 
dyslipidaemia and high FBG. The high prevalence of 
obesity might have contributed to the high prevalence 
of the other CVD risk factors in the present study.  
The study, however, had limitations. The sample 
size was small and was not uniform in terms of 
gender, as women predominated. 
5. Conclusion
The prevalence of hyperuricaemia and other
cardiometabolic risks was high among type 2 
diabetes patients. The female diabetics had more 
adverse CVD risk profile than the male diabetics. 
Waist circumference and BMI increased with 
increasing diabetes duration, but not after 20 years, 
whereas FBS decreased with increasing diabetes 
duration.  
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